行情

RLM

RLM

Realm Therapeutics
NASDAQ

实时行情|Nasdaq Last Sale

2.500
-0.010
-0.40%
已退市 16:00 07/30 EDT
开盘
2.560
昨收
2.510
最高
2.760
最低
2.450
成交量
9.40万
成交额
--
52周最高
13.00
52周最低
1.350
市值
--
市盈率(TTM)
--
分时
5日
1月
3月
1年
5年

RLM 新闻

  • 微软第二季度营收超预期 股价盘后涨超2%
  • 新浪美股.1小时前
  • 收盘:美联储利率不变 美股收盘基本持平
  • 新浪美股.1小时前
  • 美联储声明对比:措辞鲜有变化 居民支出由强劲转温和
  • 新浪财经.1小时前
  • 周三美油收跌0.3%布油涨0.5% 市场关注库存数据
  • 新浪美股.1小时前

更多

热门股票

名称
价格
涨跌幅

RLM 简况

Realm Therapeutics plc, formerly PuriCore plc, is a biopharmaceutical company. The Company is focused on leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company has initiated drug development programs based on its hypochlorous acid technology. The Company is engaged in the development of small molecule therapies with potential application for the treatment of diseases in a number of therapeutic areas, and an initial focus in dermatology and ophthalmology. The Company has developed proprietary formulations of its technology, with anti-inflammatory and immunomodulatory benefits. Its pipeline of products include PR013 and PR022, which are in Phase I. PR013 is indicated for allergic conjunctivitis and PR022 is indicated for atopic dermatitis. Realm Therapeutics, Inc. is a subsidiary of the Company.
展开

Webull提供Realm Therapeutics PLC 的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。